These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 6227542

  • 1. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S, Hagemeier HH.
    Fortschr Med; 1983 Oct 06; 101(37):1679-83. PubMed ID: 6227542
    [Abstract] [Full Text] [Related]

  • 2. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP, Arora PN, Anand S, Sharma SD.
    Indian J Dermatol; 1987 Apr 06; 32(2):41-4. PubMed ID: 3453353
    [No Abstract] [Full Text] [Related]

  • 3. Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
    Malfitan VA.
    Clin Ther; 1983 Apr 06; 5(3):290-8. PubMed ID: 6850723
    [Abstract] [Full Text] [Related]

  • 4. Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
    Høvding G.
    Pharmatherapeutica; 1981 Apr 06; 3(1):61-6. PubMed ID: 7033993
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic activity of a betamethasone dipropionate and salicylic acid combination in dermatology].
    La Rocca E, Di Leonardo S.
    G Ital Dermatol Venereol; 1986 Apr 06; 121(5):LXVII-LXIX. PubMed ID: 2947848
    [No Abstract] [Full Text] [Related]

  • 6. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan 06; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul 06; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 8. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.
    J Am Acad Dermatol; 2008 Sep 06; 59(3):455-63. PubMed ID: 18694678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of the therapeutic efficiency of a new preparation based on betamethasone dipropionate and salicylic acid in a water-alcohol excipient].
    Strani GF, Tomidei M.
    G Ital Dermatol Venereol; 1986 Sep 06; 121(2):XXV-XXVII. PubMed ID: 2940175
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD.
    Indian J Dermatol; 1986 Sep 06; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract] [Full Text] [Related]

  • 12. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C.
    Acta Derm Venereol Suppl (Stockh); 1994 Sep 06; 186():47. PubMed ID: 8073835
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of the efficacy and tolerance of betamethasone dipropionate and salicylic acid in steroid-sensitive dry dermatosis].
    Zambruno G, Lembo G, Laria G.
    G Ital Dermatol Venereol; 1986 Sep 06; 121(4):XLVII-L. PubMed ID: 3759131
    [No Abstract] [Full Text] [Related]

  • 14. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug 06; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 15. Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
    Elie R, Durocher LP, Kavalec EC.
    J Int Med Res; 1983 Aug 06; 11(2):108-12. PubMed ID: 6852357
    [Abstract] [Full Text] [Related]

  • 16. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC.
    Skin Therapy Lett; 2009 May 06; 14(4):1-4. PubMed ID: 19585059
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
    English JS, Bunker CB, Ruthven K, Dowd PM, Greaves MW.
    Clin Exp Dermatol; 1989 Jan 06; 14(1):32-4. PubMed ID: 2680178
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
    Leer JA.
    Clin Ther; 1980 Jan 06; 3(3):156-67. PubMed ID: 7006810
    [Abstract] [Full Text] [Related]

  • 19. [Treatment with topical corticosteroids in severe or resistant dermatoses].
    Nolting S.
    Derm Beruf Umwelt; 1985 Jan 06; 33(4):140-4. PubMed ID: 2931266
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of the efficacy of and tolerance of betamethasone 17,21 dipropionate and salicylic acid in dermatoses of the scalp].
    Bosco G.
    G Ital Dermatol Venereol; 1985 Jan 06; 120(2):XXV-XXVII. PubMed ID: 4007947
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.